After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of science the second Trump administration wants to back: in vivo cell ...

GLP-1s may confer greater protection from major adverse cardiovascular events compared with sulfonylureas, dipeptidyl-peptidase IV inhibitors and SGLT2 inhibitors in patients with type 2 diabetes, ...

The FDA has approved a once-monthly injection of Eli Lilly’s Omvoh for maintenance therapy in adult patients with moderately to severely active ulcerative colitis, supplanting its previous ...